tiprankstipranks
Eli Lilly and Company Canadian Depositary Receipt (TSE:LLY)
TSX:LLY
Canadian Market

Compare Eli Lilly and Company Canadian Depositary Receipt (LLY) vs. Competitors

9 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Eli Lilly and Company Canadian Depositary Receipt
C$1.23T
38.69
-13.03%
Roche Holding Ltd CAD Hedged CIBC CDR
C$441.87B
15.09%
Novartis AG CAD Hedged CIBC CDR
C$388.96B
16.93%
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged
C$231.88B
-23.07%
Johnson & Johnson Shs
C$796.27B
20.48
14.64%
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
C$416.19B
2.69
15.08%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TSE:LLY
Eli Lilly and Company Canadian Depositary Receipt
33.85
-5.00
-12.88%
TSE:ROG
Roche Holding Ltd CAD Hedged CIBC CDR
24.79
3.68
17.41%
TSE:NVS
Novartis AG CAD Hedged CIBC CDR
28.59
4.62
19.26%
TSE:NOVO
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged
15.64
-4.19
-21.13%
TSE:JNJ
Johnson & Johnson Shs
30.70
4.06
15.25%
TSE:MRK
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
27.32
3.75
15.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts